This editorial provides an overview of recent advancements in heart failure pathophysiology, prognostic biomarkers, and therapeutic outcomes, including the benefits of beta-blockers in the elderly and empagliflozin in patients with atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Adamo et al. (2020) conducted an editorial in Heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: